Double-walled microparticles for single shot vaccine

Journal of Controlled Release

Volumn 44, Issue 2-3, 1997, Pages 283-293

  Lee, Hyeon Kook ^a   Park, Jung Hwan ^a   Kwon, Kyu Chan ^a  

^a LG Chemical Ltd   (South Korea)

Author keywords

double walled microparticle; hepatitis B surface antigen; poly lactide co glycolide ; single shot vaccine; spray drying

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETONE; ACETONITRILE; ALUMINUM POTASSIUM SULFATE; BENZENE; CARBON TETRACHLORIDE; CHLOROFORM; DICHLOROMETHANE; DIOXANE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HYDROXYPROPYLCELLULOSE; MICROSPHERE; ORGANIC SOLVENT; POLYGLACTIN; POLYSORBATE 80; RECOMBINANT HEPATITIS B VACCINE; RECOMVAX B; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; FEMALE; GUINEA PIG; MICROENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUBCUTANEOUS DRUG ADMINISTRATION; TECHNIQUE;

EID: 0031575557     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01534-9     Document Type: Article

References (43)

1. R. Langer and J. Folkman, Polymers for the sustained release of proteins and other macromolecules, Nature 263 (1976) 797-800.
2. R. Langer, New methods of drug delivery, Science 249 (1990) 1527-1533.
3. D.T. O'Hagan, J.P. McGee, J. Holmgren, A.M.C.L. Mowat, A.M. Donachie, K.H.G. Mills, W. Gaisford, D. Rahman and S.J. Challacombe, Biodegradable microparticles for oral immunization, Vaccine 11 (1993) 149-154.
4. D.T. O'Hagan, K. Palin, S.S. Davis, P. Artursson and I. Sjoholm, Microparticles as potentially orally active immunologic adjuvants, Vaccine 7 (1989) 421-424.
5. J. Kohn, S.M. Niemi, E.C. Albert, J.C. Murphy, R. Langer and J.G. Fox, Single-step immunization using a controlled release, biodegradable polymer with sustained adjuvant activity, J. Immunol. Methods 95 (1986) 31-38.
6. Y. Men, G. Corradin, C. Thomasin, H.P. Merkle and B. Gander, Immunopotentiation of a synthetic antigen by incorporation into biodegradable microspheres, Proc. Int. Symp. Control. Rel. Bioact. Mater. 21 (1994) 50-51.
7. P.B. O'Donnell, M. Iwata and J.M. McGinity, Properties of multiphase microspheres of poly(DL-lactide-co-glycolic acid) prepared by a potentiometric dispersion techniques, J. Microencapsulation 12(2) (1995) 155-163.
8. C.R. Middaugh, Biophysical approaches to the pharmaceutical development of proteins, Drug Dev. Ind. Pharm. 16 (1990) 2635-2654.
9. R.E. Spier, Meeting on vaccine strategies for tomorrow, Vaccine 11 (1993) 1450-1452.
10. M.T. Aguado and P.H. Lambert, Controlled-release vaccines-biodegradable polylactide/polyglycolide(PL/PG) microspheres as antigen vehicles, Immunobiology 184 (1992) 113-125.
11. M.J. Alonso, R.K. Gupta, C. Min, G.R. Siber and R. Langer, Biodegradable microspheres as controlled-release tetanus toxoid delivery systems, Vaccine 12 (1994) 299-306.
12. M.Z.I. Khan, J.P. Opdebeeck and I.G. Tucker, Immunopotentiation and delivery systems for antigens for single-step immunization: recent trends and progress, Pharm. Res. 11(1) (1994) 2-11.
13. W. Morris, M.C. Steinhoff and P.K. Russell, Potential of polymer microencapsulation technology for vaccine innovation, Vaccine 12 (1994) 5-11.
14. R.K. Gupta, G.R. Siber, M.J. Alonso and R. Langer, Development of a single-dose tetanus toxoid based on controlled release from biodegradable and biocompatible polyester microspheres. In: H.S. Ginsberg, F. Brown, R.M. Chanock and R.A. Lerner (Eds.), Vaccine 93: Modern Approaches to New Vaccines Including Prevention of Aids, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, NY, 1993, pp. 391-396.
15. D.H. Jones, B.W. McBride, H. Jeffery, D.T. O'Hagan, A. Robinson and G.H. Farrar, Protection of mice from bordetella pertussis respiratory infection using microencapsulated pertussis fimbriae, Vaccine 13 (1995) 675-681.
16. F. Gavilanes, J. Gomez-Gutierrez, M. Aracil, J.M. Gonzalez-Ros, J.A. Ferragut, E. Guerrero and D.L. Peterson, Hepatitis B surface antigen, Biochem. J. 265 (1990) 857-864.
17. K.J. Pekarek, J.S. Jacob and E. Mathiowitz, Double-walled polymer microspheres for controlled drug release, Nature 367 (1994) 258-260.
18. A. Gopferich, M.J. Alonso and R. Langer, Development and characterization of microencapsulated microspheres, Pharm. Res. 11(11) (1994) 1568-1574.
19. T.G. Park, M.J. Alonso and R. Langer, Controlled release of proteins from poly(L-lactic acid) coated polyisobutylcyanoacrylate microcapsules, J. Appl. Polym. Sci. 52 (1994) 1797-1807.
20. R.V. Nellore, P.G. Pande, D. Young and H.R. Bhagat, Evaluation of biodegradable microspheres as vaccine adjuvant for hepatitis B Surface antigen, J. Parent. Sci. Technol. 46(5) (1992) 176-180.
21. B. Gander, E. Wehrli, R. Alder and H.P. Merkle, Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection, J. Microencapsulation 12(1) (1995) 83-97.
22. F. Pavanetto, I. Genta, P. Giunchedi and B. Conti, Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation, J. Microencapsulation 10(4) (1993) 487-497.
23. F. Pavanetto, B. Conti, I. Genta and P. Giunchedi, Solvent evaporation, solvent extraction and spray drying for polylactide microsphere preparation, Int. J. Pharm. 84 (1992) 151-159.
24. M.J. Alonso, S. Cohen, T.G. Park, R.K. Gupta, G.R. Siber and R. Langer, Determinants of release rate of tetanus vaccine from polyester microspheres, Pharm. Res. 10(7) (1993) 945-953.
25. M. Singh, A. Singh and G.P. Talwar, Controlled delivery of diphtheria toxoid using biodegradable poly(D,L-lactide) microspheres, Pharm. Res. 8(7) (1991) 958-961.
26. C. Yan, W. Rill, J. Hewetson, R. Tammariello, R. Malli and M. Kende, Persistence of immunity to ricin toxin evoked by vaccine incorporated into polylactide-co-glycolide (PLG) microparticles, Proc. Int. Symp. Control. Rel. Bioact. Mater. 21 (1994) 52-53.
27. T. Uchida, S. Martin, T.P. Foster, R.C. Wardley and S. Grimm, Dose and load studies for subcutaneous and oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin, Pharm. Res. 11(7) (1994) 1009-1015.
28. I.H. Kim, K.J. Lim, S.M. Lee, Y.S. Kwon and H.H. Chung, Purification method of hepatitis B surface antigen, KR Patent 65305, Sept. 8, 1993.
29. J. Kreuter, Physicochemical characterization of polyacrylic nanoparticles, Int. J. Pharm. 14 (1983) 43-58.
30. O.H. Lowry, Protein measurement with the folin phenol reagent, J. Biol. Chem. 193 (1951) 265-275.
31. Inactive Ingredients for Currently Marketed Products, Interpharm, Buffalo Grove, Ill., 1991.
32. R.J. Lewis, Sr., Food Additive Handbook, Van Nostrand Reinhold, New York, NY, 1989.
33. Auzyme EIA, Abbott Laboratories, Production literature.
34. Ausab EIA, Abbott Laboratories, Production literature.
35. K. Yamaguchi and J.M. Anderson, In vivo biocompatibility studies of medisorb 65/35 D,L-lactide/glycolide copolymer microspheres, J. Control. Rel. 24 (1993) 81-93.
36. M. Kanke, R. Geissler, D. Powell, A. Kaplan and P. DeLuca, Interaction of microspheres with blood constituents. III. Macrophage phagocytosis of various types of polymeric drug carriers, J. Parent. Sci. 42 (1988) 157-165.
37. M. Kanke, E. Morlier, R. Geissler, D. Powell, A. Kaplan and P. DeLuca, Interaction of microspheres with blood constituents. II. Uptake and biodegradable particles by macrophages, J. Parent. Sci. 40 (1986) 114-118.
38. D.T. O'Hagan, H. Jeffery and S.S. Davis, Long-term antibody response in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles, Vaccine 11 (1993) 965-969.
39. J.H. Eldridge, J.K. Staas, J.A. Meulbroek, T.P. Tice and R.M. Gilley, Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralising antibodies, Infect. Immun. 59 (1991) 2978-2986.
40. R.E. Johnson, L.A. Lanaski, V. Gupta, M.J. Griffin, H.T. Guad, T.E. Needham and H. Zia, Stability of atriopeptin III in poly(DL-lactic-co-glycolide) microspheres, J. Control. Rel. 17 (1991) 61-68.
41. B. Gander, C. Thomasin, H.P. Merkle, Y. Men and G. Corradin, Pulsed tetanus toxoid release from PLGA-microspheres and its relevance for immunogenicity in mice, Proc. Int. Symp. Control. Rel. Bioact. Mater. 20 (1993) 65-66.
42. G. Ada, Strategies for exploiting the immune system in the design of vaccines, Mol. Immunol. 28(3) (1991) 225-230.
43. J. Gomez-Gutierrez, I. Rodriguez-Crespo, J.M. Gonzalez-Ros, J.A. Ferragut, D.A. Paul, D.L. Peterson and F. Gavilanes, Thermal stability of hepatitis B surface antigen S protein, Biochim. Biophys. Acta 1119 (1992) 225-231.